arrow
E

Ewa Chmielik

Maria Sklodowska-Curie National Research Institute of Oncology
H指数:33
被引数:5,526

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Primary Human Papillomavirus Screening Versus Cytology for Detection of Cervical Intraepithelial Neoplasia Grade 2 or Higher in Poland: a Parallel-Group, Randomized Controlled Trial

人乳头瘤病毒初筛与细胞学检测在波兰用于检测宫颈上皮内瘤变2级或以上病变的比较:一项平行组随机对照试验

2026-05-080
OAAI
TERT promoter variants in risk stratification of Polish patients with papillary thyroid carcinoma

波兰乳头状甲状腺癌患者风险分层中的TERT启动子变异

2026-04-290
PRE
Prognostic value of baseline FDG PET/CT in HER2-positive metastatic breast cancer treated with first-line trastuzumab, pertuzumab, and docetaxel

基线FDG PET/CT对接受一线曲妥珠单抗、帕妥珠单抗和多西他赛治疗的HER2阳性转移性乳腺癌的预后价值

2025-12-100
OAAI
Tumor Cellularity Assessment Using Artificial Intelligence Trained on Immunohistochemistry-Restained Slides Improves Selection of Lung Adenocarcinoma Samples for Molecular Testing

基于在免疫组化重染切片上训练的人工智能进行肿瘤细胞密度评估,可改善肺腺癌样本分子检测的选择。

2025-01-010
OAAI
Imaging PD-L1 in the brain-Journey from the lab to the clinic

大脑中的成像PD-L1-从实验室到诊所的旅程

2024-10-280
OAAI
Tailoring advanced breast cancer treatment after cyclin-dependent kinase 4/6 inhibitors progression - real-world data analysis

定制细胞周期蛋白依赖性激酶4/6抑制剂进展后的晚期乳腺癌治疗-真实世界数据分析

2024-06-070
OAAI
Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer
2024-03-010
OAAI
Determinants of the level of circulating-tumor HPV16 DNA in patients with HPV-associated oropharyngeal cancer at the time of diagnosis

诊断时HPV相关口咽癌患者循环肿瘤HPV16 DNA水平的决定因素

2023-12-013
OAAI
In patients with well-differentiated neuroendocrine tumours, there is no apparent benefit of somatostatin analogues after disease control by peptide receptor radionuclide therapy

在分化良好的神经内分泌肿瘤患者中,通过肽受体放射性核素治疗控制疾病后,生长抑素类似物没有明显的益处

2022-05-037
PRE